In both cohorts, proliferating and nonproliferating CD8+ T cells were associated with similar clinicopathologic features, including proximal tumor location, lower stage, poor differentiation, absence of lymphovascular invasion, deficient MMR status, and mutant BRAF status (Supplementary Table S8). The gene discussed is BRAF; the disease is neoplasm.